$CCXI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ChemoCentryx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ChemoCentryx, Inc.. Get notifications about new insider transactions in ChemoCentryx, Inc. for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 22 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 15,127 | 30,254 | 15,127 | 0 to 15.1 K |
Jan 22 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 4.02 | 10,637 | 42,726 | 0 | 10.6 K to 0 (-100.00 %) |
Jan 22 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 10,637 | 21,274 | 10,637 | 0 to 10.6 K |
Jan 20 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 14,971 | 29,942 | 25,764 | |
Jan 20 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 6,134 | 12,268 | 40,735 | |
Jan 20 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 300 | 600 | 46,869 | |
Jan 20 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 4.10 | 14,971 | 61,341 | 0 | 15 K to 0 (-100.00 %) |
Jan 20 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 14,971 | 29,942 | 14,971 | 0 to 15 K |
Jan 20 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 4.05 | 6,134 | 24,826 | 0 | 6.1 K to 0 (-100.00 %) |
Jan 20 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 6,134 | 12,268 | 6,134 | 0 to 6.1 K |
Jan 20 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 4.00 | 300 | 1,200 | 0 | 300 to 0 (-100.00 %) |
Jan 20 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 300 | 600 | 300 | 0 to 300 |
Jan 12 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 10,224 | 20,448 | 47,169 | |
Jan 12 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 5.12 | 10,224 | 52,347 | 0 | 10.2 K to 0 (-100.00 %) |
Jan 12 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 10,224 | 20,448 | 10,224 | 0 to 10.2 K |
Jan 11 2016 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | P | 4.63 | 20,000 | 92,512 | 59,600 | 39.6 K to 59.6 K (+50.51 %) |
Jan 06 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 2,776 | 5,552 | 57,393 | |
Jan 06 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 34,341 | 68,682 | 60,169 | |
Jan 06 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 10,490 | 20,980 | 94,510 | |
Jan 06 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 6.55 | 2,776 | 18,195 | 0 | 2.8 K to 0 (-100.00 %) |
Jan 06 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 2,776 | 5,552 | 2,776 | 0 to 2.8 K |
Jan 06 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 6.90 | 34,341 | 236,874 | 0 | 34.3 K to 0 (-100.00 %) |
Jan 06 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 34,341 | 68,682 | 34,341 | 0 to 34.3 K |
Jan 06 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 7.38 | 10,490 | 77,379 | 0 | 10.5 K to 0 (-100.00 %) |
Jan 06 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 10,490 | 20,980 | 10,490 | 0 to 10.5 K |
Dec 14 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | P | 7.30 | 4,621 | 33,724 | 39,600 | 35 K to 39.6 K (+13.21 %) |
Dec 14 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | P | 7.23 | 15,379 | 111,202 | 34,979 | 19.6 K to 35 K (+78.46 %) |
Nov 05 2015 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | Sell | J | 0.00 | 2,384,577 | 0 | 0 | 2.4 M to 0 (-100.00 %) | |
Nov 05 2015 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | Sell | S | 7.00 | 287,000 | 2,009,057 | 2,384,577 | 2.7 M to 2.4 M (-10.74 %) | |
Nov 05 2015 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | Sell | S | 6.98 | 73,000 | 509,343 | 2,671,577 | 2.7 M to 2.7 M (-2.66 %) | |
Nov 02 2015 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 6.97 | 50,000 | 348,515 | 2,744,577 | 2.8 M to 2.7 M (-1.79 %) |
Jul 30 2015 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Option Exercise | A | 0.00 | 20,301 | 0 | 20,301 | |
Jun 11 2015 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 9.01 | 31,000 | 279,229 | 2,794,577 | 2.8 M to 2.8 M (-1.10 %) |
Jun 11 2015 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 9.00 | 924,700 | 8,322,392 | 2,825,577 | 3.8 M to 2.8 M (-24.66 %) |
May 29 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 7.51 | 13,513 | 101,515 | 13,514 | 27 K to 13.5 K (-50.00 %) |
May 26 2015 | CCXI | ChemoCentryx, Inc. | KLEIN IRA | Director | Option Exercise | M | 0.00 | 27,027 | 0 | 0 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | KLEIN IRA | Director | Option Exercise | A | 0.00 | 11,795 | 0 | 11,795 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | KLEIN IRA | Director | Sell | S | 7.44 | 10,811 | 80,484 | 16,216 | 27 K to 16.2 K (-40.00 %) |
May 26 2015 | CCXI | ChemoCentryx, Inc. | KLEIN IRA | Director | Buy | M | 0.00 | 27,027 | 0 | 27,027 | 0 to 27 K |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | M | 0.00 | 27,027 | 0 | 0 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 11,795 | 0 | 11,795 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Sell | S | 7.45 | 12,703 | 94,593 | 14,324 | 27 K to 14.3 K (-47.00 %) |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Buy | M | 0.00 | 27,027 | 0 | 27,027 | 0 to 27 K |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 27,027 | 0 | 0 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 11,795 | 0 | 11,795 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 27,027 | 0 | 27,027 | 0 to 27 K |
May 26 2015 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Option Exercise | M | 0.00 | 27,027 | 0 | 0 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Option Exercise | A | 0.00 | 11,795 | 0 | 11,795 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Buy | M | 0.00 | 27,027 | 0 | 67,027 | 40 K to 67 K (+67.57 %) |
May 26 2015 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Option Exercise | M | 0.00 | 27,027 | 0 | 0 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Option Exercise | A | 0.00 | 11,795 | 0 | 11,795 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Buy | M | 0.00 | 27,027 | 0 | 37,027 | 10 K to 37 K (+270.27 %) |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 6,527 | 3,916 | 0 | |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 16,540 | 9,924 | 6,527 | |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 1,200 | 720 | 23,067 | |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.36 | 6,527 | 48,047 | 2,148,667 | 2.2 M to 2.1 M (-0.30 %) |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 6,527 | 3,916 | 2,155,194 | 2.1 M to 2.2 M (+0.30 %) |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.55 | 16,540 | 124,920 | 2,148,667 | 2.2 M to 2.1 M (-0.76 %) |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 16,540 | 9,924 | 2,165,207 | 2.1 M to 2.2 M (+0.77 %) |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.51 | 1,200 | 9,009 | 2,148,667 | 2.1 M to 2.1 M (-0.06 %) |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 1,200 | 720 | 2,149,867 | 2.1 M to 2.1 M (+0.06 %) |
Mar 27 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 900 | 540 | 24,267 | |
Mar 27 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.57 | 900 | 6,812 | 2,148,667 | 2.1 M to 2.1 M (-0.04 %) |
Mar 27 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 900 | 540 | 2,149,567 | 2.1 M to 2.1 M (+0.04 %) |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 16,765 | 10,059 | 25,167 | |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 19,291 | 11,575 | 41,932 | |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 14,315 | 8,589 | 61,223 | |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.80 | 16,765 | 130,839 | 2,148,667 | 2.2 M to 2.1 M (-0.77 %) |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 16,765 | 10,059 | 2,165,432 | 2.1 M to 2.2 M (+0.78 %) |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.77 | 19,291 | 149,858 | 2,148,667 | 2.2 M to 2.1 M (-0.89 %) |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 19,291 | 11,575 | 2,167,958 | 2.1 M to 2.2 M (+0.90 %) |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 8.00 | 14,315 | 114,458 | 2,148,667 | 2.2 M to 2.1 M (-0.66 %) |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 14,315 | 8,589 | 2,162,982 | 2.1 M to 2.2 M (+0.67 %) |
Mar 20 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 8,467 | 5,080 | 75,538 | |
Mar 20 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 9,679 | 5,807 | 84,005 | |
Mar 20 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 8.24 | 8,467 | 69,794 | 2,148,667 | 2.2 M to 2.1 M (-0.39 %) |
Mar 20 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 8,467 | 5,080 | 2,157,134 | 2.1 M to 2.2 M (+0.39 %) |
Mar 20 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 8.42 | 9,679 | 81,516 | 2,148,667 | 2.2 M to 2.1 M (-0.45 %) |
Mar 20 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 9,679 | 5,807 | 2,158,346 | 2.1 M to 2.2 M (+0.45 %) |
Mar 18 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 8,590 | 5,154 | 93,684 | |
Mar 18 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 22,726 | 13,636 | 102,274 | |
Mar 18 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 8.58 | 8,590 | 73,692 | 2,148,667 | 2.2 M to 2.1 M (-0.40 %) |
Mar 18 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 8,590 | 5,154 | 2,157,257 | 2.1 M to 2.2 M (+0.40 %) |
Mar 18 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 8.54 | 22,726 | 194,128 | 2,148,667 | 2.2 M to 2.1 M (-1.05 %) |
Mar 18 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 22,726 | 13,636 | 2,171,393 | 2.1 M to 2.2 M (+1.06 %) |
Mar 09 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 7,759 | 4,655 | 0 | |
Mar 09 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 17,721 | 10,633 | 7,759 | |
Mar 09 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 8,645 | 5,187 | 25,480 | |
Mar 09 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 7.74 | 7,759 | 60,079 | 12,500 | 20.3 K to 12.5 K (-38.30 %) |
Mar 09 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 7,759 | 4,655 | 20,259 | 12.5 K to 20.3 K (+62.07 %) |
Mar 09 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 7.76 | 17,721 | 137,476 | 12,500 | 30.2 K to 12.5 K (-58.64 %) |
Mar 09 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 17,721 | 10,633 | 30,221 | 12.5 K to 30.2 K (+141.77 %) |
Mar 09 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 7.99 | 8,645 | 69,069 | 12,500 | 21.1 K to 12.5 K (-40.88 %) |
Mar 09 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 8,645 | 5,187 | 21,145 | 12.5 K to 21.1 K (+69.16 %) |
Mar 04 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 20,542 | 12,325 | 34,125 | |
Mar 04 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 5,943 | 3,566 | 54,667 | |
Mar 04 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 14,390 | 8,634 | 60,610 | |
Mar 04 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 7.92 | 20,542 | 162,686 | 12,500 | 33 K to 12.5 K (-62.17 %) |
Mar 04 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 20,542 | 12,325 | 22,043 | 1.5 K to 22 K (+1,368.55 %) |
Mar 04 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 7.81 | 5,943 | 46,430 | 12,500 | 18.4 K to 12.5 K (-32.22 %) |
Mar 04 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 5,943 | 3,566 | 18,443 | 12.5 K to 18.4 K (+47.54 %) |
Mar 04 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 8.13 | 14,390 | 116,975 | 12,500 | 26.9 K to 12.5 K (-53.51 %) |
Mar 04 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 14,390 | 8,634 | 26,890 | 12.5 K to 26.9 K (+115.12 %) |
Feb 25 2015 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | A | 8.19 | 155,000 | 1,269,450 | 155,000 | |
Feb 25 2015 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | A | 8.19 | 194,000 | 1,588,860 | 194,000 | |
Feb 25 2015 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | A | 8.19 | 40,000 | 327,600 | 40,000 | |
Feb 25 2015 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | A | 8.19 | 205,000 | 1,678,950 | 205,000 | |
Feb 25 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 8.19 | 420,000 | 3,439,800 | 420,000 | |
Nov 20 2014 | CCXI | ChemoCentryx, Inc. | Duliege Anne-Marie | EVP, Chief of Strat ... | Sell | S | 4.71 | 4,970 | 23,432 | 0 | 5 K to 0 (-100.00 %) |
Sep 22 2014 | CCXI | ChemoCentryx, Inc. | Charo Israel | SVP, Research | Option Exercise | A | 5.07 | 175,000 | 887,250 | 175,000 | |
May 23 2014 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 27,027 | 0 | 27,027 | |
May 23 2014 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 27,027 | 0 | 27,027 | |
May 23 2014 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Option Exercise | A | 0.00 | 27,027 | 0 | 27,027 | |
May 23 2014 | CCXI | ChemoCentryx, Inc. | KLEIN IRA | Director | Option Exercise | A | 0.00 | 27,027 | 0 | 27,027 | |
May 23 2014 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Option Exercise | A | 0.00 | 27,027 | 0 | 27,027 | |
May 02 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 27,726 | 16,636 | 0 | |
May 02 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 5.59 | 27,726 | 154,875 | 2,148,667 | 2.2 M to 2.1 M (-1.27 %) |
May 02 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 27,726 | 16,636 | 2,176,393 | 2.1 M to 2.2 M (+1.29 %) |
Apr 30 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 14,041 | 8,425 | 27,726 | |
Apr 30 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 18,233 | 10,940 | 41,767 | |
Apr 30 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 5.46 | 14,041 | 76,595 | 2,148,667 | 2.2 M to 2.1 M (-0.65 %) |
Apr 30 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 14,041 | 8,425 | 2,162,708 | 2.1 M to 2.2 M (+0.65 %) |
Apr 30 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 5.33 | 18,233 | 97,127 | 2,148,667 | 2.2 M to 2.1 M (-0.84 %) |
Apr 30 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 18,233 | 10,940 | 2,166,900 | 2.1 M to 2.2 M (+0.85 %) |
Apr 24 2014 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 14,712 | 8,827 | 0 | |
Apr 24 2014 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 5.72 | 14,712 | 84,195 | 12,500 | 27.2 K to 12.5 K (-54.06 %) |
Apr 24 2014 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 14,712 | 8,827 | 27,212 | 12.5 K to 27.2 K (+117.70 %) |
Apr 24 2014 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 13.92 | 6,250 | 87,009 | 12,500 | 18.8 K to 12.5 K (-33.33 %) |
Mar 28 2014 | CCXI | ChemoCentryx, Inc. | Duliege Anne-Marie | EVP, Chief of Strat ... | Option Exercise | A | 6.75 | 335,000 | 2,261,250 | 335,000 | |
Mar 19 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 20,000 | 12,000 | 60,000 | |
Mar 19 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.25 | 20,000 | 145,000 | 2,148,707 | 2.2 M to 2.1 M (-0.92 %) |
Mar 19 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 20,000 | 12,000 | 2,168,707 | 2.1 M to 2.2 M (+0.93 %) |
Feb 20 2014 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | A | 7.10 | 190,000 | 1,349,000 | 190,000 | |
Feb 20 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 7.10 | 395,000 | 2,804,500 | 395,000 | |
Feb 20 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 20,000 | 12,000 | 80,000 | |
Feb 20 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.05 | 20,000 | 140,932 | 2,148,707 | 2.2 M to 2.1 M (-0.92 %) |
Feb 20 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 20,000 | 12,000 | 2,168,707 | 2.1 M to 2.2 M (+0.93 %) |
Feb 20 2014 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | A | 7.10 | 200,000 | 1,420,000 | 200,000 | |
Feb 20 2014 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | A | 7.10 | 170,000 | 1,207,000 | 170,000 | |
Dec 09 2013 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | P | 5.15 | 15,000 | 77,265 | 15,000 | 0 to 15 K |
Dec 09 2013 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | P | 5.15 | 5,000 | 25,757 | 9,600 | 4.6 K to 9.6 K (+108.70 %) |
Dec 05 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.03 | 41,451 | 208,358 | 1,251,914 | 1.2 M to 1.3 M (+3.42 %) |
Dec 05 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.03 | 82,849 | 416,449 | 2,162,381 | 2.1 M to 2.2 M (+3.98 %) |
Dec 05 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.98 | 16,175 | 80,590 | 1,210,463 | 1.2 M to 1.2 M (+1.35 %) |
Dec 05 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.98 | 49,325 | 245,757 | 2,079,532 | 2 M to 2.1 M (+2.43 %) |
Nov 06 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.69 | 8,371 | 39,235 | 1,194,288 | 1.2 M to 1.2 M (+0.71 %) |
Nov 06 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.69 | 11,985 | 56,174 | 2,030,207 | 2 M to 2 M (+0.59 %) |
Nov 06 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.97 | 74,684 | 370,978 | 1,185,917 | 1.1 M to 1.2 M (+6.72 %) |
Nov 06 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.97 | 35,526 | 176,468 | 2,018,222 | 2 M to 2 M (+1.79 %) |
Nov 06 2013 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.90 | 5,500 | 26,944 | 1,111,233 | 1.1 M to 1.1 M (+0.50 %) |